.Merck defeats profits assumptions, rears sales overview on strong requirement for leading medicines like Keytruda CNBCMerck & Co. (MRK US) Defeats Profit Forecasts as Keytruda Sales Growth BloombergMerck Stock: Pharma Giant Posts Sturdy Results, Yet Outlook Drops Short Financier's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats earnings as well as sales assumptions surrounded by Keytruda strong point, yet provides combined full-year overview MarketWatch.